A A A
Onderzoek Publicaties 2007

2007

INTERNATIONALE WETENSCHAPPELIJKE PUBLICATIES (peer reviewed):

  • Anderson VM, Fernando KTM, Davies GR, Rashid W, Frost C, Fox NC, Miller DH. Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods. J Neuroimaging 2007;17:71-68.
  • Anderson VM, Bartlett JW, Fox NC, Fisniku L, Miller DH. Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates. J Neurol 2007;254:1588-1594.
  • Archer HA, McFarlane F, Frost C, Cutler D, Fox NC, Rossor MN. Symptoms of memory loss as predictors of cognitive impairment ? The use and reliability of memory ratings in a clinic population. Alzheimer Dis Assoc Disord 2007;21:101-106.
  • Barkhof F, Polvikoski TM, van Straaten ECW, Kalaria RN, Sulkava R, Aronen HJ, Niinistö L, Rastas S, Oinas M, Scheltens P, Erkinjuntti T. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology 2007;69:1521-1527.
  • Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Scahill RI, Rossor MN, Fox NC. Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiol Aging 2007;28:20-28.
  • Barnes J, Boyes RG, Lewis EB, Schott JM, Frost C, Scahill RI, Fox NC. Automatic calculation of hippocampal atrophy rates using a hippocampal template and the boundary shift integral. Neurobiol Aging 2007;28:1657-1663.
  • Barnes J, Lewis EB, Scahill RI, Bartlett JW, Frost C, Schott JM, Rossor MN, Fox NC. Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls. J Comput Assist Tomogr 2007;31:581-587.
  • Bastos-Leite AJ, van der Flier WM, van Straaten ECW, Staekenborg SS, Scheltens P, Barkhof F. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 2007;38:3182-3185.
  • van Berckel BNM, Scheltens P. Getting a grip on Alzheimer’s disease: imaging amyloid in the brain. Lancet Neurol 2007;6:204-206.
  • Bierman EJM, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman ATF. The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent? Int J Geriatr Psychiatry. 2007;22:1194-1200
  • Bierman EJM, Comijs HC, Jonker C, Beekman ATF. Symptoms of anxiety and depression in the course of cognitive decline. Dement Geriatr Cogn Disord 2007;24:213-219.
  • de Boer ME, Hertogh CMPM, Droës R-M, Riphagen II, Jonker C, and Eefsting JA. Suffering from dementia- the patient’s perspective: a review of the literature. Int Psychogeriatr 2007;19:1021-1039.
  • Bouwman FH, Schoonenboom SNM, van der Flier WM, van Elk EJ, Kok A, Barkhof F, Blankenstein MA, Scheltens Ph. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging 2007;28:1070-1074.
  • Bouwman FH, van der Flier WM, Schoonenboom NSM, van Elk EJ, Kok A, Rijmen F, Blankenstein MA, Scheltens P. Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology 2007; 69:1006-1011.
  • Camara O, Scahill RI, Schnabel JA, Crum WR, Ridgway GR, Hill DLG, Fox NC. Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal data. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 2007;10(Pt2)::785-792.
  • Carvalho-Bos SS, Riemersma-van der Lek RF, Waterhouse J, Reilly T, van Someren EJW. Strong association of the rest-activity rhythm with well-being in demented elderly women. Am J Geriatr Psychiatry 2007;15:92-100.
  • Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J. Correlations between apolipoprotein E ε4 gene dose and whole brain atrophy rates. Am J Psychiatry 2007;164:916-921.
  • Cordonnier C, van der Flier WM, Sluimer JD, Barkhof F, Scheltens P. Reply: Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2007;68:391.
  • DeCarli C, Frisoni GB, Clark CM, Harvey D, Grundman M, Petersen RC, Thal LJ, Jin S, Jack Jr CR, Scheltens P, for the Alzheimer’s Disease Cooperative Study Group. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch Neurol 2007;64:108-115.
  • Dik MG, Jonker C, Comijs HC, Deeg DJH, Kok A, Yaffe K, Penninx BW. Contribution of metabolic syndrome components to cognition in older persons. Diabetes Care 2007;30:2655-2660.
  • Dröes, R M. Insight in coping with dementia: Listening to the voice of those who suffer from it.  Aging & Mental Health 2007;11:115-118.
  • Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurol 2007;6:734-746.
  • Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ. Amyloid, hypometabolism, and cognition inAlzheimer disease; an [11C] PIB and [18F] FDG PET study. Neurology 2006;68:501-508.
  • van Es ACGM, van der Flier WM, Admiraal-Behloul F, Olofsen H, Bollen ELEM, Middelkoop HAM, Weverling-Rijnsburger AWE, van der Grond J, Westendorp RGJ, van Buchem MA. Lobar distribution of changes in gray matter and white matter in memory clinic patients: detected using magnetization transfer imaging. AJNR Am J Neuroradiol 2007;28:1938-1942.
  • Ettema TP, Droës RM, de Lange J, Mellenbergh GJ, Ribbe MW. QUALIDEM: development and evaluation of a dementia specific quality of life instrument--validation. Int J Geriatr Psychiatry 2007;22:424-430.
  • Ettema TP, Droës RM, de Lange J, Mellenbergh GJ, Ribbe MW. QUALIDEM: development and evaluation of a dementia specific quality of life instrument. Scalability, reliability and internal structure. Int J Geriatr Psychiatry. 2007;22:549-556.
  • Ettema TP, Hensen E, de Lange J, Droës RM, Mellenbergh GJ, Ribbe MW. Self report on quality of life in dementia with modified COOP/WONCA charts. Aging &Mental Health 2007;11:734-742.
  • Ewers M, Buerger K, Teipel SJ, Scheltens P, Schröder J, Zinkowski RP, Bouwman FH, Schönknecht P, Schoonenboom NSM, Andreasen N, Wallin A, DeBernardis JF, Kerkman DJ, Heindl B, Blennow K, Hampel H. Multicenter assessment of CSF-phosphorylated tau for the  prediction of conversion of MCI. Neurology 2007;69:2205-2212.
  • Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, Del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2007;6:501-512.
  • van der Flier WM, Staekenborg S, Pijnenburg YAL, Gillissen F, Romkes R, Kok A, Bouwman FH, Scheltens P. Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement Geriatr Cogn Disord 2007;23:42-46.
  • van der Flier WM, Schoonenboom NSM, Pijnenburg YAL, Fox NC, Scheltens P. The effect of APOE genotype on clinical phenotype in Alzheimer disease.(Reply from the Authors) Neurology 2007;68:624.
  • van der Flier WM, Barkhof F, Scheltens P. Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann N Y Acad Sci 2007;1097:215-224.
  • Gerritsen DL, EttemaTP, Boelens E, Bos J, Hoogeveen F, de Lange J, Meihuizen, L Schölzel-Dorenbos CJM, Dröes RM. Quality of life in dementia: do professional caregivers focus on the significant domains?  Am J Alzheimers Dis Other Dement 2007;22:176-183.
  • Gootjes L, Scheltens P, van Strien JW, Bouma A. Subcortical white matter pathology as a mediating factor for age-related decreased performance in dichotic listening. Neuropsychologia 2007;45:2322-2332.
  • Hachinski V, Skoog I, Scheltens P, Wallin A, Erkinjuntti T, Nagata K, Pasquier F, Breteler MMB, DeCarli C, Kalaria RN, Li Hsian CC, Royall DR, Román GC. Declaration of San Antonio, Texas, San Antonio, Tex., July 14,2007. Neuroepidemiology 2007;28 : 191-192.
  • Hagenbeek RE, Rombouts SARB, Veltman DJ, van Strien JW, Witter MP, Scheltens P, Barkhof F. Nonlinear changes in brain activity during continuous word repetition: an event-related multiparametric functional MR imaging study. AJNR Am J Neuroradiol 2007;28:1715-1721.
  • van Harten B, Oosterman JM, Potter van Loon B-J, Scheltens P, and Weinstein HC. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 2007;57:70-74.
  • van Harten B, Oosterman J, Muslimovic D, Potter van Loon B-J, Scheltens P, Weinstein HC. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 2007;36:164-170.
  • Holwerda TJ, Schoevers RA, Dekker J, Deeg DJH, Jonker C, Beekman ATF. The relationship between generalized anxiety disorder, depression and mortality in old age. Int J Geriatr Psychiatry 2007;22:241-249.
  • Hertogh CMPM, de Boer ME, Droes RM, Eefsting JA. Beyond a Dworkinean view on autonomy and advance directives in dementia. Response to open peer commentaries on "Would we rather lose our life than lose our self? Lessons from the Dutch debate on euthanasia for patients with dementia". Am J Bioeth 2007;7: W4-W6.
  • Hertogh CMPM, de Boer ME, Droes RM, Eefsting JA Would we rather lose our life than lose our self? Lessons from the Dutch debate on euthanasia for patients with dementia. Am J Bioeth 2007;7:48-56.
  • Jokinen H, Ryberg C, Kalska H, Ylikoski R, Rostrup E, Stegmann MB, Waldemar C, Madureira S, Ferro JM, van Straaten ECW, Scheltens P, Barkhof F, Fazekas F, Schmidt R, Carlucci G, Pantoni L, Inzitari D, Erkinjuntti T, on behalf of the LADIS group. Corpus callosum atrophy is associated with mental slowing and executive deficits in subjects with age-related white matter hyperintensities: the LADIS study. J Neurol Neurosurg Psychiatry, 2006;78:491-496.
  • Jones BF, Witter MP. Cingulate cortex projections to the parahippocampal region and hippocampal formation in the rat. Hippocampus 2007;17:957-976.
  • de Jong D, Jansen RWMM, Pijnenburg YAL, van Geel WJA, Borm GF, Kremer HPH, Verbeek MM. CSF neurofilament proteins in the differential diagnosis of dementia. J Neurol Neurosurg Psychiatry 2007;78:936-938.
  • Karas G, Scheltens P, Rombouts S, van Schijndel R, Klein M, Jones B, van der Flier W, Vrenken H, Barkhof F. Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study. Neuroradiology 2007;49:967-976.
  • Korf ESC, van Straaten ECW, de Leeuw F-E, van der Flier WM, Barkhof F, Pantoni L, Basile AM, Inzitari D, Erkinjuntti T, Wahlund L-O, Rostrup E, Schmidt R, Fazekas F, and Scheltens P, on behalf of tle Ladis Study Group. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med 2007;24:166-171.
  • Kropholler MA, Boellard R, van Berckel BNM, Schuitemaker A, Kloet RW, Lubberink MJ, Jonker C, Scheltens P, Lammertsma AA. Evaluation of reference regions for (R)-[11 C]PK11195 studies in Alzheimer’s disease and mild cognitive impairment. J Cereb Blood Flow Metab 2007;27:1965-1974.
  • Lauriks S, Reinersmann A, van der Roest HG, Meiland FJM, Davies RJ, Moelaert F, Mulvenna MD, Nugent CD, Dröes RM. Review of ICT-based services for identified unmet needs in people with dementia. Ageing Res Rev 2007;6:223-246.
  • Lauriks S, Reinersmann A, van der Roest HG, Meiland FJM, Davies RJ, Moelaert F, Mulvenna MD, Nugent CD, Dröes EM. Review of ICT-based services for identified unmet needs in perople with dementia. Aging Res Rev 2007;6:223-246.
  • Meiland FJM, Reinersmann A, Bergvall-Kareborn B, Craig D, Moelaert F, Mulvenna MD, Nugent C, Scully T, Bengtsson JE, Droës RM. COGKNOW development and evaluation of an ICT-device for people with mild dementia. Stud Helath Technol Inform 2007;127:166-177.
  • Mulder C, van der Flier WM, Veerhuis R, Bouwman F, Jakobs C, Verhoeven NM, Barkhof F, Scheltens P, Blankenstein MA. Association between vitamin B6 and white matter hyperintensities in patients with Alzheimer's disease not mediated by homocysteine metabolism. J Am Geriatr Soc 2007;55:956-958.
  • Naarding P, Tiemeier H, Breteler MMB, Schoevers RA, Jonker C, Koudstaal PJ, Beekman ATF. Clinically defined vascular depression in the general population. Psychol Med. 2007;37:383-392.
  • Oei NYL, Elzinga BM, Wolf OT, de Ruiter MB, Damoiseaux JS, Kuijer JPA, Veltman DJ, Scheltens P, Rombouts SARB. Glucocorticoids decrease hippocampal and prefrontal activation during declarative memory retrieval in young men. Brain Imaging and Behavior 2007;1:31-41.
  • Paviour DC, Price SL, Lees AJ, Fox NC. MRI derived brain atrophy in PSP and MSA-P: determining sample size to detect treatment effects. J Neurol 2007;254:478-481.
  • Petzold A, Keir G, Warren J, Fox N, Rossor MN. A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia. Neurodegeneration 2007;4:185-194.
  • Pijnenburg YAL, Janssen JC, Schoonenboom NSM, Petzold A, Mulder C, Stigbrand T, Norgren N, Heijst H, Hack CE, Scheltens P, Teunissen CE. CSF Neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls. Dement Geriatr Cogn Disord 2007;23:225-230.
  • Pijnenburg YAL, Schoonenboom SNM, Mehta PD, Mehta SP, Mulder C, Veerhuis R, Blankenstein MA, Scheltens P. Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2007;78:735-737.
  • Pijnenburg YAL. The roots of social inappropriateness in frontotemporal dementia. J Neurol Neurosurg Psychiatry 2007;78:441.
  • Podewils LJ, Guallar E, Beauchamp N, Lyketsos CG, Kuller LH, Scheltens P. Physical activity and white matter lesion progression: assessment using MRI. Neurology 2007;68:1223-1226.
  • van de Pol LA, van der Flier WM, Korf ESC, Fox NC, Barkhof F, Scheltens P. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. Neurology 2007;69:1491-1497.
  • van de Pol LA, Barnes J, Scahill RI, Frost C, Lewis EB, Boyes RG, van Schijndel RA, Scheltens P, Fox NC, Barkhof F. Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration, Neuroimage 2007;34:1036-1041.
  • van de Pol LA, Korf ESC, van der Flier WM, Brashear HR, Fox NC, Barkhof F, Scheltens P. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch Neurol 2007;64:1023-1028.
  • Ramakers IHGB, Visser PJ, Aalten P, Boesten JHM, Metsemakers JFM, Jolles J, Verhey FRJ. Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis. Dement Geriatr Cogn Disord 2007;24:300-306.
  • Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni GB, Jönsson L, Visser PJ, Ousset PJ, Vellas B, ICTUS study goup. The ICTUS study: a prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology 2007;29:29-38.
  • Ridha BH, Barnes J, van de Pol LA, Schott JM, Boyes RG, Siddique MM, Rossor MN, Scheltens P, Fox NC. Application of automated medial temporal lobe atrophy scale toAlzheimer disease. Arch Neurol 2007;64:849-854.
  • Ridha BH, Symms MR, Tozer DJ, Stockton KC, Frost C, Siddique MM, Lewis EB, MacManus DG, Boulby PA, Barker GJ, Rossor MN, Fox NC, Tofts PS. Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. AJNR Am J Neuroradiol 2007;28:965-970.
  • Ridha BH, Tozer DJ, Symms MR, Stockton KC, Lewis EB, Siddique MM, MacManus DG, Rossor MN, Fox NC, Tofts PS. Quantitative magnetization transfer imaging inAlzheimer disease. Radiology 2007;244:832-837.
  • van der Roest HG, Meiland FJN, Maroccini R, Comijs HC, Jonker C, Dröes R-M. Subjective needs of people with dementia; a review of the literature. Int Psychogeriatr 2007;19:559-592.
  • Rombouts SARB, Scheltens P, Kuijer JPA, Barkhof F. Whole brain analysis of T2* weighted baseline FMRI signal in dementia. Hum Brain Mapp 2007;28:1313-1317.
  • Ryberg C, Rostrup E, Stegmann MB, Barkhof F, Scheltens P, van Straaten ECW, Fazekas F, Schmidt R, Ferro JM, Baezner H, Erkinjuntti T, Jokinen H, Wahlund L-O, O’Brien J, Basile AM, Pantoni L, Inzitari D, Waldemar G, on behalf of the LADIS study group. Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging 2007;28:955-963.
  • Scheltens P. All patients with suspected dementia should be scanned at least once with CT or MRI. Int Psychogeriatr 2007;19:533-534.
  • Scheltens P. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer’s dissease. J Neurol Neurosurg Psychiatry 2007;78:1039.
  • Scher AI, Xu Y, Korf ESC, White LR, Scheltens P, Toga AW, Thompson PM, Hartley SW, Witter MP, Valentino DJ, Launer LJ. Hippocampal shape analysis in Alzheimer´s disease: a population-based study. Neuroimage 2007;36:8-18.
  • Schuitemaker A, van Berckel BNM, Kropholler MA, Kloet RW, Jonker C, Scheltens P, Lammertsma AA, Boellaard R. Evaluation of methods for generating parametric (R)-[11C]PK11195 binding images. J Cereb Blood Flow Metab 2007;27:1603-1615.
  • Schuitemaker A, van Berckel BNM, Kropholler MA, Veltman DJ, Scheltens P, Jonker C, Lammertsma AA, Boellaard R. SPM analysis of parametric (R)-[11C] PK11195 binding images: plasma input versus reference tissue parametric methods. Neuroimage 2007;35:1473-1479.
  • Sikkes SAM, de Lange- de Klerk ESM, Pijnenburg YAL. Instrumental activities of daily living in the screening of dementia in population studies: comment on Castlla-Rilo et al. (2007) Int J Geriatr Psychiatry 2007;22:934-935.
  • Smith SM, Rao A, De Stefano N, Jenkinson M, Schott JM, Matthews PM, Fox NC. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX. Neuroimage 2007;36:1200-1206.
  • Smits CHM, de Lange J, Dröes RM, Meiland F, Vernooij-Dassen M, Pot AM. Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review. Int J Geriatr Psychiatry. 2007;22:1181-1193.
  • Stam CJ, Jones BF, Nolte G, Breakspear M, Scheltens Ph. Small-world networks and functional connectivity in Alzheimer’s disease. Cereb Cortex 2007;17:92-99.
  • Stegeren AH van, Wolf OT, Everaerd W, Scheltens P, Barkhof F, Rombouts SARB. Endogenous cortisol level interacts with noradrenergic activation in the human amygdala. Neurobiol Learn Mem 2006;87:57-66.
  • Teodorczuk A, O’Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund L-O, Gouw A, Waldemar G, Schmidt R, Ferro JM, Chabriat H, Bäzner H, Inzitari D on behalf of the LADIS Group. White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry 2007;191:212-217.
  • Teunissen CE, Scheltens P. Use of proteomic approaches to identify disease biomarkers. Lancet Neurol 2007;6:1036-1037.
  • Verdelho A, Madureira S, Ferro JM, Basile A-M, Chabriat H, Erkinjuntti T, Fazekas F, Hennerici M, O’Brien J, Pantoni L, Salvadori E, Scheltens P, Visser MC, Wahlund L-O, Waldemar G, Wallin A, Inzitari D on behalf of the LADIS study. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry 2007;78:1325-1330.
  • Visser PJ, Kester A, Jolles J, Verhey F. Reply from the authors:Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2007;68:1239.
  • van der Vlies AE, Pijnenburg YAL, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM. Cognitive impairment in Alzheimer’s disease is modified by APOE genotype. Dement Geriatr Cogn Disord 2007;24:98-103.
  • Vogels RLC, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail 2007;9:1003-1009.
  • Vogels RLC, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 2007;9:440-449.
  • Vogels RLC, Oosterman JM, van Harten B, Gouw AA, Schroeder-Tanka JM, Scheltens P, van der Flier WM, Weinstein HC. Neuroimaging and correlates of cognitive function among patients with heart failure. Dement Geriatr Cogn Disord 2007;24:418-423.
  • Vogels RLC, Oosterman JM, van Harten B, Scheltens P, van der Flier WM, Schroeder-Tanka JM, Weinstein HC. Profile of cognitive impairment in chronic heart failure. J Am Geriatr Soc 2007;55:1764-1770.
  • Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B. Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007;14:e1-e26.
  • Wessels AM, Rombouts SARB, Remijnse PL, Boom Y, Scheltens P, Barkhof F, Heine RJ, Snoek FJ. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 2007;50:1763-1769.
  • Wessels AM, Pouwer F, Geelhoed-Duijvestijn PHLM, Snel M, Kostenset PJ, Scheltens P, Heine RJ, Snoek FJ. No evidence for increased self-reported cognitive failure in Type 1 and Type 2 diabetes: a cross-sectional study. Diabet Med 2007;24:735-740.
  • Whitwell JL, Sampson EL, Loy CT, Warren JE, Rossor MN, Fox NC, Warren JD. VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage 2007;35:207-213.
  • Ylikoski R, Jokinen H, Andersen P, Salonen O, Madureira S, Ferro J, Barkhof F, van der Flier W, Schmidt R, Fazekas F, Scheltens P, Waldemar G, Salvadori E, Pantoni L, Inzitari D, Erkinjuntti T on behalf of the LADIS Study Group. Comparison of the Alzheimer’s disease assessment scale cognitive subscale and the vascular dementia assessment scale in differentiating elderly individuals with different degrees of white matter changes. Dement Geriatr Cogn Disord 2007;24:73-81.

Boekhoofdstukken, Nederlandstalige vakpublicaties

  • Bastos Leite AJ, Barkhof F, Scheltens P. Structural brain imaging. In: S. Gauthier (ed.), Clinical diagnosis and management of Alzheimer’s disease; 3rd ed. Oxford, Informa Healthcare 2007:81-95.
  • Dozy J, van der Flier WM, Pijnenburg YAL,Scheltens Ph, Weinstein HC (red.) Dementie handboek. Een beknopte leidraad voor de praktijk; 5e dr. Utrecht, Academic Pharmaceutical Productions bv, 2007. 158 pp.
  • van der Flier W, Scheltens P. Speurtocht naar de oorzaak van geheugenverlies. In: WG van Aken et al. (red.) Vergrijzend brein - wat ouder wordende hersenen met cognitieve vermogens doen. Den Haag, Bio-Wetenschappen en Maatschappij, 2007:61-66. (Cahier 3 / 2007-26e jaargang.)
  • Jonker C, Comijs HC. Lichte Cognitieve Stoornissen (MCI): Prodromen van dementie? Tijdschr Gerontol Geriatr 2007;38:115-121.
  • Koedam ELGE, Scheltens Ph. Referaat: Een mediterraan dieet verlaagt de kans op de ziekte van Alzheimer. Ned Tijdschr Geneeskd 2007;151:440.
  • Lauriks S, Dröes RM. Ontwikkeling van de Gedragsobservatieschaal Psychomotorische therapie voor demente ouderen (GPMT-dem). Tijdschr Gerontol Geriatr 2007;38:88-99.
  • Liedorp M, Vandertop WP, Scheltens Ph. De Tarlovse cyste: onbekend en onbelangrijk ? Tschr Neurol Neurochir 2007;108:234-239.
  • Pijnenburg YAL. Frontotemporale dementie: overzicht en recente ontwikkelingen. Tijdschr Neuropsychiatrie & Gedragsneurologie 2007;6:93-97.
  • Pijnenburg YAL. Proefschriftbespreking: Frontotemporale dementie: op weg naar een vroege diagnose. Tschr Neurol Neurochir 2007;108:302-304.
  • Pijnenburg YAL. Commentaar: Alzheimer: nieuwe criteria. HealthDirect Neurologie 2007;3(6):19.
  • Pijnenburg YAL. Commentaar: Conversie van MCI naar dementie: welke factoren spelen een rol? HealthDirect Neurologie 2007;3(2):19.
  • Pijnenburg YAL. Commentaar: FAB: een geschikt screeningsinstrument ? HealthDirect Neurologie 2007;3(3):18.
  • Pijnenburg YAL. Commentaar: Hersenbiopt: diagnostisch hulpmiddel bij snelprogressieve dementie. HealthDirect Neurologie 2007;3(2):20.
  • Pijnenburg YAL. Commentaar: 100 jaar ziekte van Alzheimer. HealthDirect Neurologie 2007;3(1):17-18.
  • Pijnenburg YAL, van Swieten JC. Frontotemporal dementia with parkinsonism In: Wolters ECh, van Laar T, Berendse HW.(eds), Parkinsonism and related disorders. Amsterdam, VU University Press, 2007:283-288.
  • Rombouts SARB, Barkhof F, Scheltens P (eds), Clinical applications of functional brain MRI. Oxford, Oxford University Press, 2007. 386 pp.
  • Scheltens P. Advances in neuroimaging. In: Growdon JH, Rossor MN.(volume eds), The Dementias 2. Philadelphia, Butterworth Heinemann Elsevier, 2007:381-410.
  • Schoonenboom SNM, Bouwman FH, Scheltens Ph. Hoort liquoronderzoek thuis in de diagnostiek van (beginnende) dementie? Tschr Neurol Neurochir 2007;108:228-233.
  • Staekenborg SS, Scheltens P. Foliumzuursuppletie verbetert cognitief functioneren bij ouderen. Ned Tijdschr Geneeskd 2007;151:1544.
  • Verheij FRJ, Scheltens Ph, Olde Rikkert MGM. De ontwikkeling van geheugenpoliklinieken in Nederland. Ned Tijdschr Geneeskd 2007;151:578-580.
  • Visser PJ. Boekbespreking: HA Tuokko, DF Hultsch(red), Mild cognitive impairment: international perspectives. Philadelphia, Psychology Press, 2006. Tijdschr Neuropsychol 2007;(3):53-54.
  • van der Vlies A, Pijnenburg Y, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM. APOE-genotype beïnvloedt cognitie in ziekte van Alzheimer. Tijdschr Neuropsychol 2007;2:20-29.

Dissertaties

  • Bastos Leite AJ. Pathological ageing of the brain: a neuroimaging perspective. Enschede, Ipskamp Print Partners, 2007. 176 pp. Proefschrift Amsterdam V.U. Promotoren: F Barkhof, Ph Scheltens
  • Jones BF. Cingulate cortex networks. Role in learning and memory and Alzheimer’s disease related changes. Enschede, PrintPartners Ipskamp, 2007. 184 pp. Proefschrift Amsterdam V.U. Promotoren: Ph Scheltens, MP Witter
  • Pijnenburg YAL. Frontotemporal dementia; towards an early diagnosis. Enschede, PrintPartners Ipskamp, 2007. 188 pp. Proefschrift Amsterdam V.U. Promotoren: Ph Scheltens, C Jonker
  • van de Pol LA. Hippocampal atrophy on MRI from aging to dementia; a clinical perspective. Enschede, PrintPartners Ipskamp, 2007. 138 pp. Proefschrift Amsterdam V.U. Promotoren: Ph Scheltens, F. Barkhof Copromotor: WM van der Flier
Login naar de portal Stel een vraag Doneren

Onderzoek

Privacy | Disclaimer | © COZ Marketing 2010